Editorial
Copyright ©The Author(s) 2024.
World J Gastroenterol. Apr 14, 2024; 30(14): 1949-1957
Published online Apr 14, 2024. doi: 10.3748/wjg.v30.i14.1949
Figure 4
Figure 4 A schematic illustration indicating the relationships among metabolic-dysfunction associated steatotic liver disease, autoimmune liver diseases and autoantibody-positivity. MASLD: Metabolic-dysfunction associated steatotic liver disease; MASH: Metabolic-dysfunction associated steatohepatitis.